P3 group has strategically invested in Custom Cells, a lithium battery manufacturer, to expand their market presence and enhance production capacities in the growing electric mobility sector.
Information on the Target
Die P3 group has made a strategic investment in Custom Cells, a manufacturer of lithium batteries designed for specialized applications. Established in 2012, Custom Cells specializes in producing customer-specific electrode foils and rechargeable lithium batteries, as well as assembling battery systems tailored for niche markets. This partnership aims to leverage Custom Cells' compelling business model by sharing synergies and expanding markets.
Dr. Christoph Theis, Founder and Managing Director of P3 group, notes that the current cost competition in battery cells is expected to evolve into a performance competition. By investing in Custom Cells, P3 group seeks early access to new technologies and small series production, thus enhancing its competitiveness in the highly contested electric mobility market.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Germany
The demand for customized lithium batteries significantly surpasses the capabilities of standard cells across various specialized sectors. In the medical technology field, for instance, there is a growing requirement for high-performance, autoclavable surgical instruments
Similar Deals
MVV Energie AG → STRABAG Umwelttechnik GmbH
2023
KION Group → ifesca GmbH
2021
P3 group
invested in
Custom Cells
in 2023
in a Strategic Partnership deal